Leclerc et al., 1993 - Google Patents
Identification of helper T cell epitopes of dengue virus E-proteinLeclerc et al., 1993
- Document ID
- 579917426493844289
- Author
- Leclerc C
- Dériaud E
- Megret F
- Briand J
- van Regenmortel M
- Deubel V
- Publication year
- Publication venue
- Molecular immunology
External Links
Snippet
The T cell proliferative response to dengue 2 (Jamaica) E-glycoprotein (495 amino acids) was analyzed in vitro using either killed virus or E-protein fragments or synthetic peptides. Inactivated dengue virus stimulated dengue-specific lymph node (LN) CD4+ T cell …
- 101700021629 VEMP 0 title abstract description 48
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Collen et al. | AT cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. | |
| KR100602553B1 (en) | Synthetic Peptide Vaccines for Foot-and-Mouth Disease | |
| KR930008092B1 (en) | Peptides for the detection, diagnosis and prevention of hepatitis c. | |
| Falgout et al. | Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis | |
| JP4394019B2 (en) | Peptides that induce a cytotoxic T lymphocyte reaction against hepatitis C virus | |
| JP4216473B2 (en) | Peptide composition for prevention and treatment of HIV infection and immune disease | |
| Leclerc et al. | Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1 | |
| EP0507615A1 (en) | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) | |
| Leclerc et al. | Identification of helper T cell epitopes of dengue virus E-protein | |
| ES2123558T5 (en) | PEPTIDIC ANTIGENS OF HCV AND PROCEDURE FOR THE DETERMINATION OF HCV. | |
| Mills et al. | Extensive diversity in the recognition of influenza virus hemagglutinin by murine T helper clones. | |
| CA2135278C (en) | Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus | |
| Shirai et al. | Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines | |
| Ou et al. | Analysis of T-and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides | |
| US5582968A (en) | Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis | |
| Volpina et al. | A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model | |
| AU662954B2 (en) | Synthetic peptides for a rubella vaccine | |
| Joisson et al. | Detection of potyviruses with antisera to synthetic peptides | |
| EP0491713A1 (en) | Rubella e1 and c peptides. | |
| Mathews et al. | A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T-and B-cell epitopes | |
| Muller et al. | Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein | |
| Gershoni‐Yahalom et al. | Chimeric vaccine composed of viral peptide and mammalian heat‐shock protein 60 peptide protects against West Nile virus challenge | |
| Doel et al. | Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide | |
| US7595053B2 (en) | Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus | |
| EP0370090B1 (en) | Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |